NEKTAR THERAPEUTICS — Director's Dealing 2020

Sep 25, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2020-09-22

Reporting Person: Myriam Curet (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-22	Common Stock	A	9100	$0.00	Acquired	20800	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-22	Stock Option	$18.91	A	18200	Acquired	2028-09-21	Common Stock (18200)	Direct

Footnotes

F1: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.

F2: This restricted stock unit award vests in full, one year following September 22, 2020.

F3: This stock option vests in equal monthly installments over the one-year period beginning on September 22, 2020.